首页> 外文期刊>Modern Pathology >Histologic and Radiographic Analysis of Ductal Carcinoma In Situ Diagnosed Using Stereotactic Incisional Core Breast Biopsy
【24h】

Histologic and Radiographic Analysis of Ductal Carcinoma In Situ Diagnosed Using Stereotactic Incisional Core Breast Biopsy

机译:立体定向切口核心乳腺穿刺活检诊断导管癌的组织学和影像学分析

获取原文
           

摘要

Background: Stereotactic incisional core breast biopsy (SCBB) is a highly specific technique for diagnosing ductal carcinoma in situ (DCIS) in patients with suspicious mammographic microcalcifications. However, its sensitivity for excluding the presence of coexisting occult invasive disease in this setting is not fully established. Design: We correlated SCBB findings to subsequent lumpectomy/mastectomy (lx/mx) results in 122 cases of DCIS. In 29 of these cases, the SCBB showed microscopic invasion (n = 15) or foci that were suspicious for invasion (n = 14). Likelihood for invasive disease in subsequent lx/mx samples from each case then was compared with various parameters, including DCIS grade, extent and mammographic findings. Results: Overall, 13% of cases in which the SCBB showed DCIS only (i.e., without any evidence of invasion), had invasive disease in the subsequent excision. This finding was significantly correlated with DCIS grade (low: 0/26 [0%], intermediate: 2/31 [6%], high: 10/36 [28%], P P = .01). This was reflected by greater extent of involvement in the SCBB (5/8 cases with invasion had >15 ducts involved, versus 4/23 with P = .03). SCBB that were suspicious or positive for microinvasion demonstrated invasion in most subsequent excision (susp: 7/14 [50%], microinv: 11/15 [73%]), generally of significant extent (11/18 T1b-c). Conclusions: 1. Patients with SCBB showing high grade DCIS and DCIS suspicious or positive for microinvasion have a significant and high likelihood, respectively, of harboring occult invasive neoplasm. They should accordingly be carefully evaluated radiographically, and possibly with sentinel node biopsy to facilitate axillary staging. 2. Likelihood of occult invasion is correlated with overall DCIS size/extent.
机译:背景:立体定向切开核心乳腺活检(SCBB)是一种可疑乳腺X线微钙化患者诊断导管原位癌(DCIS)的高特异性技术。然而,在这种情况下,其排除排斥性并存隐匿性浸润性疾病的敏感性尚未完全确立。设计:我们将SCBB的发现与随后的122例DCIS的乳房切除/乳房切除术(lx / mx)结果相关联。在其中的29例中,SCBB表现为微观浸润(n = 15)或可疑浸润灶(n = 14)。然后,将每种病例随后的lx / mx样本中浸润性疾病的可能性与各种参数进行比较,包括DCIS等级,程度和乳房X线照片。结果:总体而言,SCBB仅显示DCIS(即无任何侵袭迹象)的病例中有13%在随后的切除中患有侵袭性疾病。该发现与DCIS等级显着相关(低:0/26 [0 %],中:2/31 [6 %],高:10/36 [28 %],P P = 0.01)。这反映在SCBB的介入程度更高(5/8例浸润性导管受累> 15个,而4/23例P = 0.03)。可疑或微侵袭阳性的SCBB在随后的大部分切除中均表现出侵袭性(潜能:7/14 [50 %],微侵袭:11/15 [73 %]),通常程度很大(11/18 T1b-c) 。结论:1. SCBB患者表现为高级别DCIS和可疑或微浸润阳性的DCIS,分别具有隐匿性浸润性肿瘤的可能性很高。因此,应在放射学上仔细评估它们,并可能进行前哨淋巴结活检以促进腋窝分期。 2.隐匿性入侵的可能性与DCIS的总体大小/程度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号